Page last updated: 2024-10-29

indomethacin and Pigmentary Retinopathy

indomethacin has been researched along with Pigmentary Retinopathy in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, LL1
Shannon, BT1
Leguire, LE1

Other Studies

1 other study available for indomethacin and Pigmentary Retinopathy

ArticleYear
Immune alterations associated with T lymphocyte activation and regulation in retinitis pigmentosa patients.
    Clinical immunology and immunopathology, 1988, Volume: 49, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Female; Histamine; Humans; Indomethacin; Leukocyte Count; Lymphocyte

1988